Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

NCT03049774 is registered in ClinicalTrials.gov with Angde Biotech Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03049774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03049774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor
Lead sponsor
Angde Biotech Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2017
Completion date
December 31, 2017
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced thrombocytopenia